| Kendall A Hadler, MD | |
|
3200 Sycamore Ct Ste 1b, Columbus, IN 47203-1545 | |
| (812) 378-9027 | |
| (812) 378-1014 |
| Full Name | Kendall A Hadler |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 3200 Sycamore Ct Ste 1b, Columbus, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518990530 | NPI | - | NPPES |
| 000000087832 | Other | IN | ANTHEM PIN # |
| 100327410 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 01031246A (Indiana) | Primary |
| Entity Name | Decatur County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952300477 PECOS PAC ID: 7315837671 Enrollment ID: O20040318001580 |
News Archive
Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians (ACCP), shows the drug may also provide significant benefits for children with PAH, helping to improve both oxygen delivery and exercise capacity.
Scientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that on May 28, 2010, it received a subpoena from the Dallas office of the Department of Health and Human Services, Office of Inspector General (OIG). The subpoena relates to a civil investigation that was previously disclosed by the company during its earnings call on April 27, 2010, and in its quarterly report on form 10-Q for the period ended March 31, 2010.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $2.333 million through the second tranche of a non-brokered private placement of 1,333,428 units priced at $1.75 per Unit.
Using advanced computer simulations, University of Utah College of Pharmacy researchers have produced moving images of a protein complex that is an important target for anti-cancer drugs.
› Verified 7 days ago
| Entity Name | Southeastern Indiana Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073531844 PECOS PAC ID: 7618919036 Enrollment ID: O20050525001250 |
News Archive
Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians (ACCP), shows the drug may also provide significant benefits for children with PAH, helping to improve both oxygen delivery and exercise capacity.
Scientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that on May 28, 2010, it received a subpoena from the Dallas office of the Department of Health and Human Services, Office of Inspector General (OIG). The subpoena relates to a civil investigation that was previously disclosed by the company during its earnings call on April 27, 2010, and in its quarterly report on form 10-Q for the period ended March 31, 2010.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $2.333 million through the second tranche of a non-brokered private placement of 1,333,428 units priced at $1.75 per Unit.
Using advanced computer simulations, University of Utah College of Pharmacy researchers have produced moving images of a protein complex that is an important target for anti-cancer drugs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kendall A Hadler, MD 3200 Sycamore Ct Ste 1b, Columbus, IN 47203-1545 Ph: (812) 378-9027 | Kendall A Hadler, MD 3200 Sycamore Ct Ste 1b, Columbus, IN 47203-1545 Ph: (812) 378-9027 |
News Archive
Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest Physicians (ACCP), shows the drug may also provide significant benefits for children with PAH, helping to improve both oxygen delivery and exercise capacity.
Scientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes.
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced today that on May 28, 2010, it received a subpoena from the Dallas office of the Department of Health and Human Services, Office of Inspector General (OIG). The subpoena relates to a civil investigation that was previously disclosed by the company during its earnings call on April 27, 2010, and in its quarterly report on form 10-Q for the period ended March 31, 2010.
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $2.333 million through the second tranche of a non-brokered private placement of 1,333,428 units priced at $1.75 per Unit.
Using advanced computer simulations, University of Utah College of Pharmacy researchers have produced moving images of a protein complex that is an important target for anti-cancer drugs.
› Verified 7 days ago
Dr. Jiangming Xu, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sycamore Ct Ste 1b, Columbus, IN 47203 Phone: 812-378-9027 Fax: 812-378-1014 | |
Ralph L Wischmeyer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3220 Sycamore Ct., Suite 1b, Columbus, IN 47203 Phone: 812-265-5211 Fax: 812-265-0570 | |
Dr. Robert J Oesterling, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sycamore Ct Ste 1b, Columbus, IN 47203 Phone: 812-378-9027 Fax: 812-378-1014 | |
Teal Murphy, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sycamore Ct Ste 1b, Columbus, IN 47203 Phone: 812-378-9027 Fax: 812-378-1014 | |
Dr. Richard Andrew Robertson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2400 North Park, Suite 20, Columbus, IN 47203 Phone: 812-376-0700 Fax: 812-376-8625 | |
Dr. Andrew David Powell, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sycamore Ct Ste 1b, Columbus, IN 47203 Phone: 812-378-9027 Fax: 812-378-1014 | |
Dr. Thomas Benjamin Cartwright, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Sycamore Ct Ste 1b, Columbus, IN 47203 Phone: 812-378-9027 Fax: 812-378-1014 |